Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - COST OF REVENUE
Cost of Revenue HALO - Halozyme Therapeutics, Inc.
159 M
LAST VALUE
6.98%
2 YEAR CAGR
28.47%
5 YEAR CAGR
21.50%
10 YEAR CAGR